MADISON SQUARE GARDEN SPORTS CORP.
In the published model solve dated 2026-Q2, anchored at $393.90, MADISON SQUARE GARDEN SPORTS CORP. (MSGS) is priced for today's economics sustained for ~9.1 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed June 27, 2026 from SEC EDGAR filings.
• MSG Sports owns two of the most valuable franchises in professional sports, the New York Knicks and the New York Rangers, and the stock trades less on its income statement than on the scarcity value of those teams. • The biggest risk is that the teams lose money on a reported basis, a combined $22 million after taxes and interest in fiscal 2025, so the price has no earnings cushion and rests entirely on private-market franchise values holding. • Watch the proposed split of the Knicks and Range
Is MSGS overvalued? See what's priced in →
396 institutional managers reported holding MSGS in 13F filings for the quarter ended 2026-03-31. Together they hold about 73% of the company; the top 10 hold 42%. 59 opened new positions that quarter. Held by BlackRock, Vanguard Group, Gates Foundation Trust, among others. On the short side, 1.3M shares were sold short as of the 2026-06-15 count, about 5% of shares outstanding (4.3 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
MSGS's share count is about flat over the past five years ($75.06M of repurchases, offset by issuance). It pays a dividend, and has for 4 years running; the current rate is $7.00 a share annually. Cash returned over the past three years: $1.81M in dividends.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at MSGS over the trailing three years. Absence is a fact about the company, not a signal. 11 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
MSGS's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-18 | -13.4% | -3.0% |
| 2023-11-03 | +4.0% | +1.8% |
| 2024-02-07 | +7.1% | -5.6% |
| 2024-05-04 | -0.6% | +5.5% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
MSGS's latest 8-K filings: 2026-05-08 (items 2.02, 9.01); 2026-05-04 (items 5.02, 9.01); 2026-02-18 (items 5.02, 8.01); 2026-02-05 (items 2.02, 9.01); 2025-12-09 (items 5.07).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.